← 返回首页
美国 · 平台与数据 · MarketBeat

Evolus Eyes 2027 Sculpt Launch as Filler Portfolio Expands and Revenue Grows

来源:MarketBeat · 美国 19 分钟前
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

详细摘要

Evolus (NASDAQ:EOLS) executives said the company expects its expanding lineup of injectable aesthetics products to support growth as it prepares for the anticipated launch of Evolysse Sculpt in 2027. At a company event, CEO and President David Moatazedi said Evolus has diversified beyond its flagsh

在 MarketBeat 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)

推荐阅读